The survivin-31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival

Analytical Cellular Pathology

Volumn 33, Issue 5-6, 2010, Pages 177-189

  Antonacopoulou, Anna G ^a   Floratou, Konstantina ^a   Bravou, Vasiliki ^a   Kottorou, Anastasia ^a   Dimitrakopoulos, Fotinos Ioannis ^a   Marousi, Stella ^a   Stavropoulos, Michalis ^a   Koutras, Agelos K ^a   Scopa, Chrisoula D ^a   Kalofonos, Haralabos P ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

colorectal cancer; polymorphism; splice variant; survival; Survivin

Indexed keywords

FORMALDEHYDE; ISOPROTEIN; MESSENGER RNA; PARAFFIN; SURVIVIN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FROZEN SECTION; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ALTERNATIVE RNA SPLICING; BIOSYNTHESIS; CANCER STAGING; COLORECTAL TUMOR; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY;

AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; COLORECTAL NEOPLASMS; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 79955670725     PISSN: 22107177     EISSN: 22107185     Source Type: Journal    
DOI: 10.3233/ACP-CLO-2010-0537     Document Type: Article

References (38)

1. G. Ambrosini, C. Adida and D.C. Altieri, A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma, Nat. Med. 3 (1997), 917-921. (Pubitemid 27353455)
2. A.G. Antonacopoulou, P.D. Grivas, L. Skarlas, M. Kalofonos, C.D. Scopa and H.P. Kalofonos, POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: new molecules with prognostic significance?, Anticancer Res. 28 (2008), 1221-1227. (Pubitemid 351578860)
3. A. Badran, A. Yoshida, K. Ishikawa, T. Goi, A. Yamaguchi, T. Ueda andM. Inuzuka, Identification of a novel splice variant of the human anti-apoptopsis gene survivin, Biochem. Biophys. Res. Commun. 314 (2004), 902-907. (Pubitemid 38112885)
4. A.A. Borbely, M. Murvai, K. Szarka, J. Konya, L. Gergely, Z. Hernadi and G. Veress, Survivin promoter polymorphism and cervical carcinogenesis, J. Clin. Pathol. 60 (2007), 303-306. (Pubitemid 46447748)
5. H. Caldas, L.E. Honsey and R.A. Altura, Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies, Mol. Cancer 4 (2005), 11.
6. S. De Maria, G. Pannone, P. Bufo, A. Santoro, R. Serpico, S. Metafora, C. Rubini, D. Pasquali, S.M. Papagerakis, S. Staibano, G. De Rosa, E. Farina, M. Emanuelli, A. Santarelli, M.A. Mariggio, L. Lo Russo and L. Lo Muzio, Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma, J. Cancer Res. Clin. Oncol. 135 (2009), 107-116.
7. L.F. Fan, W.G. Dong, C.Q. Jiang, Q. Qian and Q.F. Yu, Role of Hypoxia-inducible factor-1 alpha and Survivin in colorectal carcinoma progression, Int. J. Colorectal Dis. 23 (2008), 1057-1064.
8. M. Gazouli, N. Tzanakis, G. Rallis, G. Theodoropoulos, I. Papaconstantinou, A. Kostakis, N.P. Anagnou and N. Nikiteas, Survivin ?31G/C promoter polymorphism and sporadic colorectal cancer, Int. J. Colorectal Dis. 24 (2009), 145-150.
9. P.D. Grivas, A. Antonacopoulou, V. Tzelepi, G. Sotiropoulou-Bonikou, Z. Kefalopoulou, A.G. Papavassiliou and H. Kalofonos, HER-3 in colorectal tumourigenesis: from mRNA levels through protein status to clinicopathologic relationships, Eur. J. Cancer 43 (2007), 2602-2611. (Pubitemid 350103546)
10. J.S. Jang, K.M. Kim, K.H. Kang, J.E. Choi, W.K. Lee, C.H. Kim, Y.M. Kang, S. Kam, I.S. Kim, J.E. Jun, T.H. Jung and J.Y. Park, Polymorphisms in the survivin gene and the risk of lung cancer, Lung Cancer 60 (2008), 31-39. (Pubitemid 351434465)
11. J.G. Kalliakmanis, C. Kouvidou, C. Latoufis, G. Kouvatseas, D. Anagnostakis, G. Papatheodoridis, J. Koskinas and A. Archimandritis, Survivin expression in colorectal carcinomas: correlations with clinicopathological parameters and survival, Dig. Dis. Sci., Online first (2009).
12. R. Kannangai, J. Wang, Q.Z. Liu, F. Sahin and M. Torbenson, Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation, Int. J. Gastrointest Cancer 35 (2005), 53-60. (Pubitemid 40458580)
13. H. Kawasaki, D.C. Altieri, C.D. Lu, M. Toyoda, T. Tenjo and N. Tanigawa, Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer, Cancer Res. 58 (1998), 5071-5074. (Pubitemid 28521163)
14. H. Kawasaki,M. Toyoda, H. Shinohara, J. Okuda, I.Watanabe, T. Yamamoto, K. Tanaka, T. Tenjo and N. Tanigawa, Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis, Cancer 91 (2001), 2026-2032. (Pubitemid 32476366)
15. S.K. Knauer, C. Bier, P. Schlag, J. Fritzmann, W. Dietmaier, F. Rodel, L. Klein-Hitpass, A.F. Kovacs, C. Doring, M.L. Hansmann,W.K. Hofmann, M. Kunkel, C. Brochhausen, K. Engels, B.M. Lippert, W. Mann and R.H. Stauber, The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein, Cell Cycle 6 (2007), 1502-1509.
16. K. Komuro, M. Tada, E. Tamoto, A. Kawakami, A. Matsunaga, K. Teramoto, G. Shindoh, M. Takada, K. Murakawa, M. Kanai, N. Kobayashi, Y. Fujiwara, N. Nishimura, J. Hamada, A. Ishizu, H. Ikeda, S. Kondo, H. Katoh, T. Moriuchi and T. Yoshiki, Right-and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasis, J. Surg. Res. 124 (2005), 216-224. (Pubitemid 40463721)
17. S. Lankiewicz, E. Rother, S. Zimmermann, C. Hollmann, F. Korangy and T.F. Greten, Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells, Cell Oncol. 30 (2008), 463-471.
18. S. Lassmann, L. Tang, M. Capanu, T. Brabletz, A. Schopflin, A. Zur Hausen, M. Gonen, N. Kemeny, J. Shia, D. Klimstra and M. Werner, Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy, Gastroenterology 133 (2007), 1831-1839. (Pubitemid 350180803)
19. F. Li, Survivin study: what is the next wave?, J. Cell Physiol. 197 (2003), 8-29. (Pubitemid 37486223)
20. F. Li, G. Ambrosini, E.Y. Chu, J. Plescia, S. Tognin, P.C. Marchisio and D.C. Altieri, Control of apoptosis and mitotic spindle checkpoint by survivin, Nature 396 (1998), 580-584. (Pubitemid 28563719)
21. F. Li and X. Ling, Survivin study: an update of "what is the next wave"?, J. Cell Physiol. 208 (2006), 476-486. (Pubitemid 44141872)
22. F. Li, J. Yang, N. Ramnath, M.M. Javle and D. Tan, Nuclear or cytoplasmic expression of survivin: what is the significance?, Int. J. Cancer 114 (2005), 509-512. (Pubitemid 40349608)
23. C. Mahotka, M. Wenzel, E. Springer, H.E. Gabbert and C.D. Gerharz, Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties, Cancer Res. 59 (1999), 6097-6102. (Pubitemid 30035627)
24. W.H. Majoros and U. Ohler, Spatial preferences of microRNA targets in 3-untranslated regions, BMC Genomics 8 (2007), 152.
25. W.E. Mesker, G.J. Liefers, J.M. Junggeburt, G.W. van Pelt, P. Alberici, P.J. Kuppen, N.F. Miranda, K.A. van Leeuwen, H. Morreau, K. Szuhai, R.A. Tollenaar and H.J. Tanke, Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients, Cell Oncol. 31 (2009), 169-178.
26. M. Monzo, R. Rosell, E. Felip, J. Astudillo, J.J. Sanchez, J. Maestre, C. Martin, A. Font, A. Barnadas and A. Abad, A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers, J. Clin. Oncol. 17 (1999), 2100-2104. (Pubitemid 29318841)
27. W.S. Moon and A.S. Tarnawski, Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth?, Hum. Pathol. 34 (2003), 1119-1126. (Pubitemid 37466997)
28. S. Peroukides, V. Bravou, A. Alexopoulos, J. Varakis, H. Kalofonos and H. Papadaki, Survivin overexpression in HCC and liver cirrhosis differentially correlates with p-STAT3 and Ecadherin, Histol. Histopathol. 25 (2010), 299-307.
29. S. Rozen and H. Skaletsky, Primer3 on the WWW for general users and for biologist programmers, Methods Mol. Biol. 132 (2000), 365-386.
30. B. Ryan, N. O'Donovan, B. Browne, C. O'Shea, J. Crown, A.D. Hill, E. McDermott, N. O'Higgins and M.J. Duffy, Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer, Br. J. Cancer 92 (2005), 120-124. (Pubitemid 40188444)
31. P.N. Span, V.C. Tjan-Heijnen, J.J. Heuvel, J.B. de Kok, J.A. Foekens and F.C. Sweep, Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?, Clin. Chem. 52 (2006), 1693-1700. (Pubitemid 44330703)
32. K. Suga, T. Yamamoto, Y. Yamada, S. Miyatake, T. Nakagawa and N. Tanigawa, Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas, Oncol. Rep. 13 (2005), 891-897.
33. K. Tanaka, S. Iwamoto, G. Gon, T. Nohara, M. Iwamoto and N. Tanigawa, Expression of survivin and its relationship to loss of apoptosis in breast carcinomas, Clin. Cancer Res. 6 (2000), 127-134. (Pubitemid 30064984)
34. L.M. Veenendaal, O. Kranenburg, N. Smakman, A. Klomp, I.H. Borel Rinkes, P.J. van Diest, Differential Notch and TGFbeta signaling in primary colorectal tumors and their corresponding metastases, Cell Oncol. 30 (2008), 1-11. (Pubitemid 351161033)
35. F. Vegran, R. Boidot, C. Oudin, J.M. Riedinger and S. Lizard-Nacol, Distinct expression of Survivin splice variants in breast carcinomas, Int. J. Oncol. 27 (2005), 1151-1157.
36. Y. Xu, F. Fang, G. Ludewig, G. Jones and D. Jones, A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells, DNA Cell Biol. 23 (2004), 527-537. (Pubitemid 39244331)
37. T. Zhang, T. Otevrel, Z. Gao, Z. Gao, S.M. Ehrlich, J.Z. Fields and B.M. Boman, Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer, Cancer Res. 61 (2001), 8664-8667. (Pubitemid 34013874)
38. N. Zhu, L. Gu, H.W. Findley, F. Li and M. Zhou, An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy, Oncogene 23 (2004), 7545-7551. (Pubitemid 39389696)